Mochi vs Henry Meds
Last updated: May 21, 2026
Quick Answer: Mochi Health and Henry Meds are both legitimate telehealth platforms that prescribe GLP-1 medications like semaglutide and tirzepatide for weight loss. Mochi offers a more comprehensive lifestyle coaching program, while Henry Meds focuses on low-cost compounded GLP-1 access. If price is your top priority, Henry Meds tends to be cheaper. If you want structured support alongside your medication, Mochi may be the better fit — but read on, because the right choice depends on several factors most comparison articles skip.
Key Takeaways
- Mochi Health combines GLP-1 prescriptions with dietitian coaching and behavior support, making it more of a full weight-loss program.
- Henry Meds focuses on affordable access to compounded semaglutide and tirzepatide with minimal program overhead.
- Henry Meds is generally cheaper per month, but Mochi’s bundled coaching may deliver better long-term results for some users.
- Neither platform accepts insurance for GLP-1 medications in most cases, though both offer self-pay pricing.
- Both platforms are staffed by licensed medical providers and are considered legitimate telehealth services.
- Compounded GLP-1 medications from both services are not FDA-approved branded products (like Ozempic or Wegovy), but are legally prescribed compounded versions.
- People with uncontrolled high blood pressure, a history of thyroid cancer, or pancreatitis may not qualify for either service.
- Shipping typically takes 3–7 business days after prescription approval.
- If neither service fits your budget, affordable GLP-1 options without insurance do exist and are worth exploring.
What Exactly Are Mochi and Henry Meds, and How Are They Different?
Mochi Health is a telehealth weight-loss platform that pairs GLP-1 medication prescriptions with ongoing dietitian support, behavioral coaching, and app-based tracking. Henry Meds is a telehealth subscription service focused primarily on prescribing compounded GLP-1 medications at a lower monthly cost, with less emphasis on lifestyle programming.
Both platforms operate fully online. You complete a health intake form, consult with a licensed provider (usually asynchronously or via video), and receive a prescription for compounded semaglutide or tirzepatide if you qualify. The key structural difference is that Mochi wraps the medication in a coaching ecosystem, while Henry Meds keeps things lean and affordable.
Choose Mochi if: You want accountability, meal guidance, and a structured program alongside your medication.
Choose Henry Meds if: You’ve already done your research, know what you want, and just need affordable access to compounded GLP-1 medication.
How Much Does Each Platform Cost? (Mochi vs Henry Meds Pricing)
Henry Meds is typically the more affordable option. As of 2026, Henry Meds compounded semaglutide starts at roughly $197–$297 per month depending on dose, while Mochi Health’s programs generally range from $149 to over $400 per month, with the higher tiers including more coaching and support.
Approximate monthly cost comparison (2026 estimates):
| Platform | Starting Price | Includes Coaching? | Medication Type |
|---|---|---|---|
| Henry Meds | ~$197/month | No | Compounded semaglutide/tirzepatide |
| Mochi Health | ~$149–$400/month | Yes (higher tiers) | Compounded semaglutide/tirzepatide |
Neither platform routinely accepts insurance for GLP-1 weight-loss medications. Both charge out of pocket. Prices can change based on dosage adjustments, so always confirm current pricing directly on each platform before enrolling.
💡 If cost is your biggest concern, it’s also worth checking DirectMeds GLP1 Semaglutide — currently one of the most affordable compounded semaglutide options available online in 2026. Check DirectMeds pricing here →
Are Mochi and Henry Meds Legitimate Telehealth Services?
Yes, both Mochi Health and Henry Meds are legitimate, licensed telehealth platforms. They employ state-licensed physicians, nurse practitioners, and physician assistants who review your medical history and prescribe medications within legal guidelines.
Both platforms prescribe compounded GLP-1 medications, which are legally manufactured by FDA-registered compounding pharmacies. These are not counterfeit or black-market products. However, compounded semaglutide and tirzepatide are not FDA-approved in the same way branded Ozempic or Wegovy are — they are custom-compounded versions, which is a legal and common practice in the U.S. when brand-name drugs are on the FDA shortage list.
Common mistake: Some people assume “compounded” means lower quality. In reality, compounded medications from licensed 503B pharmacies follow strict quality standards. The difference is regulatory classification, not necessarily efficacy.
How Quickly Do Medications From Mochi and Henry Meds Arrive?
Most patients receive their medication within 5–10 business days after their prescription is approved. Approval itself can take 24–72 hours after submitting your intake form, depending on provider availability.
Henry Meds ships from partner compounding pharmacies and typically delivers in 3–7 business days post-approval. Mochi Health follows a similar timeline, though delivery speed can vary by pharmacy partner and your location.
Edge case: If you live in a state with stricter telehealth prescribing laws (such as certain restrictions in some Southern states), approval may take longer or require a synchronous video visit before prescribing.
What Side Effects Should You Watch Out For?
The most common side effects of compounded semaglutide and tirzepatide — the GLP-1 medications prescribed by both Mochi and Henry Meds — include nausea, vomiting, diarrhea, constipation, and reduced appetite. These are typically most noticeable during dose escalation and often improve over time.
More serious but less common side effects include:
- Pancreatitis (severe abdominal pain)
- Gallbladder problems
- Rapid heart rate
- Injection site reactions
- Potential risk of thyroid C-cell tumors (noted in animal studies; avoid if you have a personal or family history of medullary thyroid carcinoma)
Both platforms require you to disclose your full medical history during intake. If side effects are severe, each platform has a provider team you can message for guidance. For a broader look at how medications can affect your body long-term, see this overview on long-term effects of medications on prostate enlargement as one example of systemic medication impact.
Can I Use Henry Meds or Mochi If I Have High Blood Pressure?
Having high blood pressure does not automatically disqualify you from either platform, but it does require careful provider review. Both Mochi and Henry Meds screen for cardiovascular risk during intake. If your blood pressure is controlled with medication, you may still qualify. Uncontrolled hypertension is typically a disqualifying factor.
GLP-1 medications have actually shown some favorable effects on blood pressure and cardiovascular markers in clinical research, which is part of why they’re being studied beyond weight loss. However, providers on both platforms will evaluate your specific situation before prescribing.
Decision rule: If you have high blood pressure, be upfront in your intake form. Hiding it won’t help and could create a safety risk.
Which Service Is Better for Different Ages and Goals?
For adults in their 30s, Henry Meds often works well because younger users tend to be more self-directed, comfortable with digital-only platforms, and motivated by cost savings. The lower price point and straightforward prescription model suit people who don’t need hand-holding.
For adults in their 50s and beyond, Mochi’s coaching model may offer more value. Metabolic changes, comorbidities, and the need for dietary adjustments become more complex with age. Having dietitian access built into the program can make a meaningful difference in outcomes. If you’re over 50 and focused on staying active during your weight-loss journey, pairing your GLP-1 program with strategies from our guide on how to stay fit and active at home after age 50 can accelerate your results.
Are There Generic or Cheaper Alternatives to These Services?
Yes. Compounded semaglutide and tirzepatide are themselves the lower-cost alternatives to branded drugs like Ozempic, Wegovy, and Zepbound. Beyond Mochi and Henry Meds, other telehealth platforms offer similar services, including Ro, Hims & Hers, and Found.
One option worth highlighting is DirectMeds GLP1 Semaglutide, which positions itself as one of the most affordable compounded semaglutide programs currently available. If you’re comparing costs across platforms, it belongs on your shortlist. See DirectMeds GLP1 pricing and enrollment →
For a full breakdown of low-cost GLP-1 access, our cheapest GLP-1 without insurance guide covers the top platforms side by side.
How Do I Know If I’m a Good Candidate for Mochi or Henry Meds?
Most GLP-1 telehealth platforms, including Mochi and Henry Meds, require a BMI of 30 or higher, or a BMI of 27+ with at least one weight-related health condition (such as type 2 diabetes, hypertension, or sleep apnea). You must also be 18 or older and not pregnant or breastfeeding.
You are likely a good candidate if:
- Your BMI meets the threshold above
- You don’t have a personal or family history of medullary thyroid carcinoma or MEN2 syndrome
- You don’t have active pancreatitis or severe gastrointestinal disease
- You’re not currently on medications with serious GLP-1 interactions
You may not qualify if you have uncontrolled cardiovascular disease, certain kidney conditions, or a history of eating disorders — though each case is evaluated individually.
What Happens If the Medication Doesn’t Work for Me?
If you’re not seeing results after 8–12 weeks at an effective dose, both platforms allow provider consultations to reassess your plan. This might mean a dose increase, a switch from semaglutide to tirzepatide (which some studies suggest produces greater weight loss on average), or a review of lifestyle factors.
Neither Mochi nor Henry Meds offers a formal money-back guarantee on medication results, since individual response to GLP-1s varies. However, both allow you to cancel your subscription without long-term contracts.
Common mistake: Stopping the medication too early. GLP-1 medications often take 4–8 weeks to show meaningful weight changes, especially at lower starting doses.
Can I Get a Free Consultation? What About Insurance Coverage?
Henry Meds and Mochi Health both offer low-cost or free initial consultations as part of their intake process. You typically pay nothing upfront until a provider approves your prescription and you choose a plan.
Regarding insurance: most major insurance plans do not cover GLP-1 medications prescribed specifically for weight loss (as opposed to type 2 diabetes). Both Mochi and Henry Meds operate on a self-pay model for weight-loss GLP-1 prescriptions. Some HSA/FSA accounts may be usable for these costs — check with your plan administrator.
🔥 Ready to start? DirectMeds GLP1 Semaglutide offers one of the most competitive self-pay prices for compounded semaglutide in 2026. Start your free consultation with DirectMeds →
Common Mistakes People Make When Using These Online Med Services
Mochi vs Henry Meds users often run into the same avoidable problems. Here are the most frequent ones:
- Underreporting medical history on intake forms, which can lead to unsafe prescriptions or disqualification after the fact.
- Skipping dose escalation schedules and increasing too fast, which dramatically worsens nausea and GI side effects.
- Expecting fast results without dietary changes. GLP-1 medications work best alongside reduced calorie intake and increased activity.
- Canceling too early after mild side effects in the first few weeks, before the body adjusts.
- Not tracking progress — weight, energy, and appetite changes should be logged to help your provider make informed adjustments.
- Choosing a platform based on price alone without considering whether you need coaching support to stay consistent.
For users who want to support their weight-loss results naturally alongside GLP-1 therapy, exploring liquid fat burner supplements or reviewing a nutrition system program can complement your medication plan.
Frequently Asked Questions
Is Mochi Health or Henry Meds better for weight loss?
Both platforms prescribe the same class of medications (GLP-1 agonists), so clinical outcomes depend more on medication adherence and lifestyle changes than on the platform itself. Mochi’s coaching model may improve adherence for some users, while Henry Meds’ lower cost reduces the financial barrier to starting.
Does Henry Meds prescribe tirzepatide?
Yes, Henry Meds prescribes compounded tirzepatide in addition to compounded semaglutide. Tirzepatide (the active ingredient in Zepbound and Mounjaro) targets both GLP-1 and GIP receptors and has shown stronger average weight loss in clinical trials compared to semaglutide alone.
Is compounded semaglutide the same as Ozempic or Wegovy?
No. Compounded semaglutide contains the same active ingredient but is not manufactured by Novo Nordisk and is not FDA-approved as a finished drug product. It is legally compounded by licensed pharmacies, typically at a significantly lower cost than branded versions.
Can I switch from Mochi to Henry Meds (or vice versa)?
Yes. Neither platform locks you into a long-term contract. You can cancel one subscription and enroll in another. Your new provider will conduct their own intake review before prescribing.
How long do I need to stay on a GLP-1 medication?
Most clinical guidance suggests GLP-1 medications are most effective as long-term treatments. Weight often returns after stopping. Your provider on either platform can help you develop a long-term maintenance plan.
What if I have blood sugar concerns alongside weight issues?
Both platforms screen for diabetes and metabolic conditions during intake. GLP-1 medications were originally developed for type 2 diabetes management, so they can be appropriate for people with blood sugar concerns. For additional support, review our guide on blood sugar supplements for diabetics as a complementary resource.
Do Mochi or Henry Meds require in-person visits?
No. Both platforms are fully telehealth-based. All consultations happen online via intake forms, asynchronous messaging, or video calls depending on your state’s requirements.
Is DirectMeds a good alternative to Mochi and Henry Meds?
Yes. DirectMeds GLP1 Semaglutide is a strong alternative, particularly for cost-conscious users. It offers compounded semaglutide at competitive pricing with a straightforward online enrollment process. Compare DirectMeds pricing here →
Conclusion: Which Platform Should You Choose?
The Mochi vs Henry Meds decision comes down to two things: how much support you need and how much you want to spend.
If you’re self-motivated, already understand GLP-1 medications, and want to minimize monthly costs, Henry Meds is a solid, legitimate choice. If you want a structured program with coaching and accountability built in, Mochi Health justifies its higher price for many users.
That said, if you’re still shopping around, DirectMeds GLP1 Semaglutide deserves a serious look as one of the most affordable compounded semaglutide programs in 2026. It combines accessible pricing with a straightforward medical intake process — no unnecessary upsells.
Your next steps:
- Check your BMI and any qualifying health conditions before applying to any platform.
- Compare current pricing directly on each platform, as rates change frequently.
- Be fully honest on your intake form — it protects you and gets you the right dose.
- Set realistic expectations: most users see meaningful results in 8–16 weeks with consistent use.
👉 Start with DirectMeds GLP1 Semaglutide — Check Today’s Price →
Tags: Mochi vs Henry Meds, GLP-1 telehealth, compounded semaglutide, tirzepatide online, Henry Meds review, Mochi Health review, weight loss telehealth, semaglutide cost 2026, online GLP-1 prescription, Ozempic alternatives, affordable weight loss medication, telehealth weight loss program
